Xoma | XOMA - Efectivo Y Equivalentes





Efectivo Y Equivalentes Cambio Fecha
AbbVie USD 9.39B 4.16B 2026-03
Agenus USD 35M 32M 2026-03
Agios Pharmaceuticals USD 113.6M 24.47M 2026-03
Ardelyx USD 31.21M 36.79M 2026-03
aTyr Pharma USD 10.01M 735K 2026-03
BioMarin Pharmaceutical USD 2.22B 910.76M 2026-03
Celldex Therapeutics USD 35.73M 6.86M 2026-03
Curis USD 10.14M 10.14M 2025-06
Eli Lilly USD 5.28B 1.99B 2026-03
Emergent BioSolutions USD 111.7M 23.9M 2023-12
Incyte USD 4.02B 435.22M 2026-03
MacroGenics USD 66.52M 9.3M 2026-03
Novartis USD 6.88B 4.56B 2026-03
Novartis USD 9.56B 2.9B 2025-09
Pfizer USD 1.7B 561M 2026-03
Prothena USD 329.46M 21.93M 2026-03
Regeneron Pharmaceuticals USD 2.96B 15.9B 2026-03
Xoma USD 143.9M 7.68M 2024-06